Parkinsonian syndrome diagnosed after alpha-synuclein skin test: Case
A 45-year-old man initially deemed to have depression was later diagnosed with parkinsonian syndrome following a skin biopsy that detected alpha-synuclein,…
Articles by Katherine Poinsatte, PhD
Light therapy trial shows feasibility of home studies in Parkinson’s
Early data on recruitment and enrollment from Photopharmics’ Phase 3 clinical trial of its light-based, at-home therapy device for Parkinson’s…
Texas scientist wins MJFF prize for Parkinson’s research
The Michael J. Fox Foundation for Parkinson’s Research (MJFF) recognized a Texas scientist for his contributions to Parkinson’s research…
Oral GT-02287 seen to safely reach adult brain cells in Phase 1 trial
An investigational treatment for Parkinson’s disease known as GT-02287 safely led to a roughly 53% increase in GCase enzyme…
Antibiotic, antifungal use show slight links to Parkinson’s in study
People who received five or more courses of penicillin antibiotic treatment in the five years before a Parkinson’s diagnosis…
Findings in fruit flies could lead to new Parkinson’s stem cell therapies
A process known as SUMOylation plays an important role in the so-called waking up of neural stem cells, a type…
Study will test ALX-001’s drug interactions in Parkinson’s disease
Allyx Therapeutics has received a $3.3 million grant from the National Institutes of Health (NIH) to initiate a Phase…
Magnetic field technology controls key cells in brain tied to Parkinson’s
A novel technology based on gene therapy enables precise and noninvasive control of specific brain circuits using magnetic fields, allowing…
Scientists seek causes of Parkinson’s neuropsychiatric symptoms
New U.S. Department of Defense-funded research at Binghamton University in New York is investigating the underlying causes of neuropsychiatric symptoms…
BPGbio, University of Oxford team up on treatments for Parkinson’s
The Centre for Medicines Discovery at the University of Oxford and BPGbio, an artificial intelligence (AI)-focused biopharmaceutical company,…